Anti-Depressants Flashcards
(60 cards)
Depressed Mood most of the time for at least 2 weeks and/or loss of interest or pleasure in most activities
Major Depressive Disorder
Anti-depressant drug usage
- Antidepressant drugs were the most commonly prescribed medications in the USA.
- Their primary indication is for treatment of MDD. It has received FDA approvals for the treatment of:
- panic disorder
- generalized anxiety disorder (GAD)
- post-traumatic stress disorder (PTSD)
- obsessive-compulsive disorder (OCD).
- Commonly used to treat pain disorders such as:
- neuropathic pain
- pain associated with fibromyalgia.
Mono-Amine Hypothesis:
Depression results from a deficiency in ammount or function of cortical and limbic Serotonin, Norepinephrine and dopamine
Neurotrophic hypothesis:
Brain derived neurotropic factor (BDNF) is critical for regulation of neural plasticisty and neurogenesis. In depression there is loss of BDNF in hippocampus
MAOI
work at the presynaptic nerve terminal to prevent the breakdown of dopamine, NE and Seratonin
What is the lag time between initiation of therapy and response to anti-depressants?
1-4 weeks
SSRIs
➢ Fluoxetine ➢ Fluvoxamine ➢ Sertraline ➢ Paroxetine ➢ Citalopram ➢ Escitalopram
Pharmacodynamics of SSRIs
➢ SSRIs inhibit serotonin transporter (SERT)
➢ Block only serotonin (not NE) reuptake- Elevated serotonin levels
Depression results from a deficiency in ammount or function of cortical and limbic Serotonin, Norepinephrine and dopamine
Mono-Amine Hypothesis
Which SSRIs are CYP inhibitors?
- Fluoxetine (CYP2D6 inhibitor)
- paroxetine (CYP2D6 inhibitor)
- fluvoxamine (CYP3A4 inhibitor)
A/E and DI of SSRIs
➢ Sexual Dysfunction (↓libido) in up to 40% of all patients→reason for non compliance
➢ Nausea, diarrhea
➢ Weight gain—Paroxetine
➢ Drug Interactions:
• Fluoxetine, paroxetine: CYP2D6 inhibitors → possible drug interactions
• Fluvoxamine CYP3A4 inhibitor
• sertraline, citalopram and escitalopram no DI
➢ Serotonin Syndrome (with MAOIs)
Pharmacokinetics of SSRIs
➢ Fluoxetine is metabolized to active norfluoxetine long elimination half life.
• Hence it has to be discontinued 4 weeks or longer before an MAOI can be administered to reduce risk of serotonin syndrome
➢ Fluoxetine and paroxetine are CYP2D6 inhibitors
➢ Fluvoxamine CYP3A4 inhibitor
➢ Modest CYP interactions:
• sertraline
• citalopram
• escitalopram
SSRIs with modest CYP interactions
- sertraline
- citalopram
- escitalopram
these have no drug interactions
Brain derived neurotropic factor (BDNF) is critical for regulation of neural plasticisty and neurogenesis. In depression there is loss of BDNF in hippocampus
Neurotrophic hypothesis
SSRI that causes weight gain
Paroxetine
What drug combination puts a patient at risk for serotonin syndrome
SSRIs and MAOIs
Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
- venlafaxine
- desvenlafaxine
- duloxetine
Seratonin-NE Reuptake Inhibitors
a) SNRIs (Selective Seratonin-NE Reuptake Inhibitors
b) TCAs
TCAs
- Amitriptyline
- Desipramine
- Doxepin
- Imipramine
- Nortriptyline
- trimipramine
- clomipramine
- protriptyline
PK and PD of SNRIs and TCAs
➢ Pharmacodynamics:
• Both TCAs and SNRIs bind both the serotonin (SERT) and the norepinephrine transporters (NET)
• and inihibit reuptake of serotonin and NE
➢ The SNRIs differ from the TCAs in that they lack:
• the potent antihistamine
• α adrenergic blocking
• antimuscarinic effects of the TCAs.
• As a result, the SNRIs tend to be favored over the TCAs in the treatment of MDD and pain syndromes because of their better tolerability.
➢ Among TCAs, clomipramine has more affinity to bind to SERT.
• This selectivity for the serotonin transporter contributes to clomipramine’s known benefits in the treatment of OCD.
Side Effects of SNRIs and TCAs
➢ SNRIs: serotonergic A/E (diarrhea, vomiting) and noradrenergic effects- ↑ BP and HR, and CNS activation, such as insomnia, anxiety, and agitation.
➢ TCAs-
➢ Alpha-1 Blockade: orthostatic hypotension, sexual dysfunction, cardiac conduction delays (QT prolongation)
➢ Histamine Blockade: weight gain, sedation
➢ Anti cholinergic: Dry mouth, Blurred vision, constipation, urinary hesitancy
➢ Sexual Dysfunction
➢ Lowers seizure threshold – seizures may occur (especially in overdoses)
• TCA Over dose = 3 C’s:
• Coma, Convulsions, Cardiac arrythmias (Rx- IV NaHCO3)
Side effects of histamine blockade
Weight gain and sedation
How do SNRIs differ from TCAs
SNRIs lack: • the potent antihistamine • α adrenergic blocking • antimuscarinic effects of the TCAs. • As a result, the SNRIs tend to be favored over the TCAs in the treatment of MDD and pain syndromes because of their better tolerability.
clomipramine
a) a TCAs
b) has more affinity to bind to SERT.
c) used to treat OCD
d) This selectivity for the serotonin transporter contributes to clomipramine’s known benefits in the treatment of OCD.
